help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dufort, I.
Right arrow Articles by Luu-The, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dufort, I.
Right arrow Articles by Luu-The, V.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*OMIM
*Protein*UniGene
*Substance via MeSH
The Journal of Clinical Endocrinology & Metabolism Vol. 86, No. 2 841-846
Copyright © 2001 by The Endocrine Society

Original Studies

Human Types 1 and 3 3{alpha}-Hydroxysteroid Dehydrogenases: Differential Lability and Tissue Distribution1

Isabelle Dufort2, Fernand Labrie and Van Luu-The

Oncology and Molecular Endocrinology Research Center, Laval University Medical Center (CHUL) and Laval University, Québec G1V 4G2, Canada

Address correspondence and requests for reprints to: Dr. Van Luu-The, Oncology and Molecular Endocrinology Research Center, Laval University Medical Center (CHUL), 2705 Laurier Boulevard, Québec G1V 4G2, Canada.

3{alpha}-Hydroxysteroid dehydrogenases (3{alpha}-HSDs) catalyze the conversion of 3-ketosteroids to 3{alpha}-hydroxy compounds. The best known 3{alpha}-HSD activity is the transformation of the most potent natural androgen, dihydrotestosterone, into 5{alpha}-androstan-3{alpha},17ß-diol (3{alpha}-diol), a compound having much lower activity. Previous reports show that 3{alpha}-HSDs are involved in the metabolism of glucocorticoids, progestins, prostaglandins, bile acid precursors, and xenobiotics. 3{alpha}-HSDs could, thus, play a crucial role in the control of a series of active steroid levels in target tissues. In the human, type 1 3{alpha}-HSD was first identified as human chlordecone reductase. Recently, we have isolated and characterized type 3 3{alpha}-HSD that shares 81.7% identity with human type 1 3{alpha}-HSD. The transfection of vectors expressing types 1 and 3 3{alpha}-HSD in transformed human embryonic kidney (HEK-293) cells indicates that both enzymes efficiently catalyze the transformation of dihydrotestosterone into 3{alpha}-diol in intact cells. However, when the cells are broken, the activity of type 3 3{alpha}-HSD is rapidly lost, whereas the type 1 3{alpha}-HSD activity remains stable. We have previously found that human type 5 17ß-HSD which possesses 84% and 86% identity with types 1 and 3 3{alpha}-HSD, respectively, is also labile, whereas rodent enzymes such as mouse type 5 17ß-HSD and rat 3{alpha}-HSD are stable after homogenization of the cells. The variable stability of different enzymatic activities in broken cell preparations renders the comparison of different enzymes difficult. RNA expression analysis indicates that human type 1 3{alpha}-HSD is expressed exclusively in the liver, whereas type 3 is more widely expressed and is found in the liver, adrenal, testis, brain, prostate, and HaCaT keratinocytes. Based on enzymatic characteristics and sequence homology, it is suggested that type 1 3{alpha}-HSD is an ortholog of rat 3{alpha}-HSD while type 3 3{alpha}-HSD, which must have diverged recently, seems unique to human and is probably more involved in intracrine activity.




This article has been cited by other articles:


Home page
 J EndocrinolHome page
P.-G. Blanchard and V. Luu-The
Differential androgen and estrogen substrates specificity in the mouse and primates type 12 17{beta}-hydroxysteroid dehydrogenase
J. Endocrinol., August 1, 2007; 194(2): 449 - 455.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Q. Ji, L. Chang, F. Z. Stanczyk, M. Ookhtens, A. Sherrod, and A. Stolz
Impaired Dihydrotestosterone Catabolism in Human Prostate Cancer: Critical Role of AKR1C2 as a Pre-Receptor Regulator of Androgen Receptor Signaling
Cancer Res., February 1, 2007; 67(3): 1361 - 1369.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
K. Blouin, C. Richard, G. Brochu, F.-S. Hould, S. Lebel, S. Marceau, S. Biron, V. Luu-The, and A. Tchernof
Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men
J. Endocrinol., December 1, 2006; 191(3): 637 - 649.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
F Labrie, V Luu-The, A Belanger, S-X Lin, J Simard, G Pelletier, and C Labrie
Is dehydroepiandrosterone a hormone?
J. Endocrinol., November 1, 2005; 187(2): 169 - 196.
[Abstract] [Full Text] [PDF]

Home page
 Protein Sci.Home page
J.-F. Couture, K. Pereira De Jesus-Tran, A.-M. Roy, L. Cantin, P.-L. Cote, P. Legrand, V. Luu-The, F. Labrie, and R. Breton
Comparison of crystal structures of human type 3 3{alpha}-hydroxysteroid dehydrogenase reveals an "induced-fit" mechanism and a conserved basic motif involved in the binding of androgen
Protein Sci., June 1, 2005; 14(6): 1485 - 1497.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
K. Blouin, S. Blanchette, C. Richard, P. Dupont, V. Luu-The, and A. Tchernof
Expression and activity of steroid aldoketoreductases 1C in omental adipose tissue are positive correlates of adiposity in women
Am J Physiol Endocrinol Metab, February 1, 2005; 288(2): E398 - E404.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
D. R. Bauman, S. I. Rudnick, L. M. Szewczuk, Y. Jin, S. Gopishetty, and T. M. Penning
Development of Nonsteroidal Anti-Inflammatory Drug Analogs and Steroid Carboxylates Selective for Human Aldo-Keto Reductase Isoforms: Potential Antineoplastic Agents That Work Independently of Cyclooxygenase Isozymes
Mol. Pharmacol., January 1, 2005; 67(1): 60 - 68.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. Blouin, C. Richard, C. Belanger, P. Dupont, M. Daris, P. Laberge, V. Luu-The, and A. Tchernof
Local Androgen Inactivation in Abdominal Visceral Adipose Tissue
J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5944 - 5950.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
T. L. Rizner, H. K. Lin, D. M. Peehl, S. Steckelbroeck, D. R. Bauman, and T. M. Penning
Human Type 3 3{alpha}-Hydroxysteroid Dehydrogenase (Aldo-Keto Reductase 1C2) and Androgen Metabolism in Prostate Cells
Endocrinology, July 1, 2003; 144(7): 2922 - 2932.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Quinkler, C. Bumke-Vogt, B. Meyer, V. Bahr, W. Oelkers, and S. Diederich
The Human Kidney Is a Progesterone-Metabolizing and Androgen-Producing Organ
J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2803 - 2809.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
L. Vergnes, J. Phan, A. Stolz, and K. Reue
A cluster of eight hydroxysteroid dehydrogenase genes belonging to the aldo-keto reductase supergene family on mouse chromosome 13
J. Lipid Res., March 1, 2003; 44(3): 503 - 511.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2001 by The Endocrine Society